导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -19.67% | 4632/4982 |
| 近一周 | -4.47% | 4923/5419 |
| 近一月 | -6.60% | 3983/5423 |
| 近一季 | -22.57% | 4957/5358 |
| 近半年 | -27.27% | 4989/5131 |
| 近一年 | -17.61% | 4100/4733 |
| 近两年 | 59.74% | 1876/4208 |
| 近三年 | 32.00% | 1649/3661 |
| 成立以来 | 368.98% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.28% 2189/5130 |
8.39% 2821/5464 |
- - |
- - |
| 2025 | 66.06% 378/5130 |
29.40% 30/4624 |
-4.06% 4279/4802 |
38.27% 952/4970 |
-3.27% 3071/5130 |
| 2024 | 2.09% 2248/4618 |
-5.77% 2785/4340 |
-2.50% 2285/4442 |
15.21% 836/4550 |
-3.55% 2664/4618 |
| 2023 | -15.44% 1956/4216 |
2.35% 1688/3759 |
-2.11% 1216/3909 |
-10.96% 2735/4055 |
-5.21% 2174/4209 |
| 2022 | -21.12% 1312/3578 |
-20.69% 2084/2804 |
7.66% 1464/3205 |
-5.72% 310/3430 |
-2.01% 1965/3570 |
| 2021 | -6.17% 1274/2717 |
-9.20% 1396/1745 |
16.48% 521/2232 |
-9.78% 1712/2560 |
-1.68% 1816/2708 |
| 2020 | 66.27% 342/1596 |
2.62% 257/1036 |
27.77% 356/1256 |
8.78% 770/1472 |
16.57% 515/1690 |
| 2019 | 50.72% 234/926 |
26.99% 715/3054 |
-1.48% 1859/3201 |
15.62% 78/939 |
4.20% 853/1014 |
| 2018 | -43.51% 528/668 |
- - |
- - |
- - |
-15.05% 2712/2977 |
| 2017 | 27.98% 79/531 |
- - |
- - |
- - |
- - |
| 2016 | 1.52% 35/455 |
- - |
- - |
- - |
- - |
| 2015 | 104.32% 7/433 |
- - |
- - |
- - |
- - |
| 2014 | 14.52% 314/432 |
- - |
- - |
- - |
- - |
| 2013 | 20.94% 123/398 |
- - |
- - |
- - |
- - |
| 2012 | -10.16% 454/459 |
- - |
- - |
- - |
- - |
| 2011 | -24.91% 235/392 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 54.69% |
| 招商创新增长混合A | 1.0759 | 54.25% |
| 招商创新增长混合C | 1.0235 | 53.96% |
| 华泰柏瑞医疗健康A | 2.6422 | 49.29% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 招商品质成长混合A | 1.0435 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 47.23% |
| 大摩优悦安和混合C | 0.8828 | 47.08% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 大摩健康产业混合A | 1.9440 | 32.70% |
| 国泰估值优势混合(LOF)A VS. 长安宏观策略混合A(740001) |